ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
binx health™ Submits Request for Emergency Use Authorization for First CRISPR-based Point-of-care Test for COVID-19
May 19, 2021Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences -
binx health receives EUA Authorizing at-Home COVID-19 Sample Collection by Universities, Employers
December 16, 2020binx health has received an amendment to its COVID-19 Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), this time for centralized specimen collection kit distribution and retrieval by large partners.
Pharma Sources Insight January 2025
